Damon Runyon Researchers

Meet Our Scientists
Adrienne A. Boire, MD, PhD

Leptomeningeal metastasis, or spread of cancer cells into the spinal fluid, is a devastating complication of cancer resulting in rapid neurologic disability and death. With little mechanistic information to guide treatment decisions, efforts at treatment are too often futile. To address this critical knowledge gap, Adrienne will employ a translational approach to analyze patient samples utilizing multiple, complementary, orthogonal molecular strategies as tools for discovery. This approach will be coupled with hypothesis-driven mouse models to assemble coherent molecular mechanisms that describe cancer cell interactions with their microenvironment. This mechanistic work will suggest new targets for therapeutic intervention, paving the way for novel treatment approaches. Dr. Boire works under the mentorship of Joan Massagué, PhD, at Memorial Sloan Kettering Cancer Center, New York, New York.

Project title: "Molecular determinants of leptomeningeal metastasis: a translational approach"
Institution: Memorial Sloan Kettering Cancer Center
Named Award: William Raveis Charitable Fund Scientist
Award Program: Clinical Investigator
Sponsor(s) / Mentor(s): Joan Massagué, PhD
Cancer Type: Brain
Research Area: Cancer Genetics